2021 LUNGevity Health Equity for Communities Research Award
LUNGevity’s Health Equity for Communities Research Award program supports young researchers interested in lung cancer community-based participatory research (CBPR) as a way to establish impact and sustainability for quality outcomes or health equity in high-risk populations.
- Applicants must be within the first five years of their faculty appointment.
- The Health Equity for Communities Research Awards are mentored awards; a mentoring plan is part of the required submission.
Projects that will be funded in 2021 are expected to have a direct impact on disparities in vulnerable populations in the areas of lung cancer screening, biomarker testing, or inclusion in clinical research.
Health Equity for Communities Research Awards may be for a maximum of $250,000:
- $125,000 per year for 2 years
- Annual milestones must be met
Note: LUNGevity will grant only one Health Equity for Communities Research Award per institution.
LUNGevity uses a two-step application process:
- A letter of intent (LOI), with a brief overview of the proposed project and biographical information
- A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants is invited to submit a full application after the LOI review is completed.)
Awardees have progress and financial reporting obligations during their award term.
A complete description, terms and conditions, and instructions are included in the 2021 LUNGevity Health Equity for Communities Research Award RFA. All application materials must be submitted electronically via proposalCENTRAL, which will be open for applications as of May 5, 2021.
2021 Health Equity for Communities Research Award Timeline
LOIs due: | by June 4, 2021, 11:59 pm EST |
Full application invitations: | No earlier than July 14, 2021 |
Full application due (by invitation only): | August 20, 2021, 11:59 pm EDT |
Award announcement: | Fall 2021 |
Anticipated year-one funding: | November 2021 |